Sign Out
No interaction studies have been performed. For the treatment of GPP flares, spesolimab is not expected to cause cytokine mediated CYP interaction as a perpetrator.
Live vaccines should not be given concurrently with spesolimab (see Precautions).
There is limited experience from the use of spesolimab in combination with immunosuppressants in GPP patients (see Precautions).
Continue with Google